Regemat 3D

Regemat 3D

HQ Country
REGEMAT 3D is a biotech company focused on regenerative medicine and pioneer in the use of 3D printing for regenerative therapies, a promising area called bioprinting. The potential of bioprinting in regenerative medicine and tissue engineering is huge. There are still many problems to be solved and many hypothesis to be tested in order to find solutions to tissue regeneration. Our mission is to develop customized innovative solutions in the area of bioprinting and regenerative medicine towards the clinical application of this amazing technology, aiming at improving people´s quality of life.
Filtered by:
Regemat 3D
12 Oct 2018

3D Printing in the Medical and Dental Industry 2019 - 2029

IDTechEx Report: Dr Nadia Tsao
26 Jul 2018

Will bioprinting be an alternative to organ transplantation?

Bioprinting has emerged during the last years as a promising technology for creating living tissues to regenerate injuries and organs. Without any doubt it is a promising technology but, how far away scientists are from creating functional tissues and organs that can be implanted in human beings? Hype or reality?
13 Mar 2018

3D Bioprinting 2018 - 2028: Technologies, Markets, Forecasts

IDTechEx Report: Dr Nadia Tsao
13 Dec 2017

Report on IDTechEx Show! USA 2017

The following article summarises some of the key observations made by IDTechEx analysts during the IDTechEx Show! It contains details of many of the companies demonstrating products during the exhibition, notable presentations given and summaries of relevant conversations and recent updates.
16 Nov 2017

3D Bioprinting : Advances In Cartilage Regeneration And Other Tissue Applications

Regemat 3D, Spain
10 Nov 2017

Tissue Engineering 2018-2028: Technologies, Markets, Forecasts

IDTechEx Report: Dr Nadia Tsao
19 Apr 2017

Regemat 3D

IDTechEx analyst Nadia Tsao interviewed Regemat 3D Business Development Manager Gloria Pinilla on April 19, 2017. Regemat 3D focuses on the development of 3D bioprinters for regenerative medicine.
Included are: